The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures: An Updated Systematic Review
Abstract
BACKGROUND: Osteoporosis is a major contributor to the propensity to fracture among older adults, and various pharmaceuticals are available to treat it. PURPOSE: To update a review about the benefits and harms of pharmacologic treatments used to prevent fractures in adults at risk. DATA SOURCES: Multiple computerized databases were searched between 2 January 2005 and 4 March 2014 for English-language studies. STUDY SELECTION: Trials, observational studies, and systematic reviews. DATA EXTRACTION: Duplicate extraction and assessment of data about study characteristics, outcomes, and quality. DATA SYNTHESIS: From more than 52 000 titles screened, 315 articles were included in this update. There is high-strength evidence that bisphosphonates, denosumab, and teriparatide reduce fractures compared with placebo, with relative risk reductions from 0.40 to 0.60 for vertebral fractures and 0.60 to 0.80 for nonvertebral fractures. Raloxifene has been shown in placebo-controlled trials to reduce only vertebral fractures. Since 2007, there is a newly recognized adverse event of bisphosphonate use: atypical subtrochanteric femur fracture. Gastrointestinal side effects, hot flashes, thromboembolic events, and infections vary among drugs. LIMITATIONS: Few studies have directly compared drugs used to treat osteoporosis. Data in men are very sparse. Costs were not assessed. CONCLUSION: Good-quality evidence supports that several medications for bone density in osteoporotic range and/or preexisting hip or vertebral fracture reduce fracture risk. Side effects vary among drugs, and the comparative effectiveness of the drugs is unclear. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality and RAND Corporation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
Reid, I. R., Brown, J. P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J.-P., Kaufman, J.-M., Jaeger, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011807 · Cited by 877
Cummings, S. R., Karpf, D. B., Harris, F., Genant, H. K., Ensrud, K., LaCroix, A. Z., & Black, D. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01124-x · Cited by 752
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00198 · Cited by 529
Self-citationOwens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. B., Chang, S., & Helfand, M. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.009 · Cited by 513
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Black, D. M., Kelly, M. P., Genant, H. K., Palermo, L., Eastell, R., Bucci-Rechtweg, C., Cauley, J., Leung, P. C., Boonen, S., Santora, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001086 · Cited by 512
Tsai, J. N., Uihlein, A. V., Lee, H., Kumbhani, R., Siwila-Sackman, E., McKay, E. A., Burnett-Bowie, S.-A. M., Neer, R. M., & Leder, B. Z. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60856-9 · Cited by 496
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493
Sarkar, S., Mitlak, B. H., Wong, M., Stock, J. L., Black, D. M., & Harper, K. D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.1 · Cited by 442
Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
Park-Wyllie, L. Y. (2011) · JAMA · doi:10.1001/jama.2011.190 · Cited by 442
Incidence of atypical nontraumatic diaphyseal fractures of the femur
Dell, R. M., Adams, A. L., Greene, D. F., Funahashi, T. T., Silverman, S. L., Eisemon, E. O., Zhou, H., Burchette, R. J., & Ott, S. M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1719 · Cited by 441
Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-5-201103010-00307 · Cited by 436
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
Bone, H. G., Bolognese, M. A., Yuen, C. K., Kendler, D. L., Wang, H., Liu, Y., & San Martin, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2814 · Cited by 425
Fracture risk and zoledronic acid therapy in men with osteoporosis
Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204061 · Cited by 359
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
Mellström, D. D., Sörensen, O. H., Goemaere, S., Roux, C., Johnson, T. D., & Chines, A. A. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0286-7 · Cited by 350
Bisphosphonates for Osteoporosis — Where Do We Go from Here?
Whitaker, M., Guo, J., Kehoe, T., & Benson, G. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1202619 · Cited by 337
Computing an Exact Confidence Interval for the Common Odds Ratio in Several 2×2 Contingency Tables
Mehta, C. R., Patel, N. R., & Gray, R. (1985) · Journal of the American Statistical Association · doi:10.1080/01621459.1985.10478212 · Cited by 328
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
Filleul, O., Crompot, E., & Saussez, S. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0907-7 · Cited by 295
Atypical fractures of the femur and bisphosphonate therapy
Giusti, A., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · Bone · doi:10.1016/j.bone.2010.05.019 · Cited by 295
Schwartz, A. V., Bauer, D. C., Cummings, S. R., Cauley, J. A., Ensrud, K. E., Palermo, L., Wallace, R. B., Hochberg, M. C., Feldstein, A. C., Lombardi, A., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.11 · Cited by 289
Bisphosphonate Associated Osteonecrosis of the Jaw
KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080759 · Cited by 280
Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?
Black, D. M., Bauer, D. C., Schwartz, A. V., Cummings, S. R., & Rosen, C. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1202623 · Cited by 279
Murad, M. H., Drake, M. T., Mullan, R. J., Mauck, K. F., Stuart, L. M., Lane, M. A., Abu Elnour, N. O., Erwin, P. J., Hazem, A., Puhan, M. A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3060 · Cited by 277 · cited 1×
“A recent network meta-analysis of 116 placebo-controlled or head-to-head trials assessing alendronate, risedronate, ibandronate, zoledronic acid, raloxifene, denosumab, teriparatide, vitamin D, and calcium concluded that any of the drugs were likely more effective than vitamin D or calcium; the evidence supporting ral…”
ResultGreen, J., Czanner, G., Reeves, G., Watson, J., Wise, L., & Beral, V. (2010) · BMJ · doi:10.1136/bmj.c4444 · Cited by 275
Bone-Density Testing Interval and Transition to Osteoporosis in Older Women
Gourlay, M. L., Fine, J. P., Preisser, J. S., May, R. C., Li, C., Lui, L.-Y., Ransohoff, D. F., Cauley, J. A., & Ensrud, K. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107142 · Cited by 273
Andrews, E. B., Gilsenan, A. W., Midkiff, K., Sherrill, B., Wu, Y., Mann, B. H., & Masica, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1768 · Cited by 272
Nakamura, T., Sugimoto, T., Nakano, T., Kishimoto, H., Ito, M., Fukunaga, M., Hagino, H., Sone, T., Yoshikawa, H., Nishizawa, Y., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3479 · Cited by 268
Gedmintas, L., Solomon, D. H., & Kim, S. C. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1893 · Cited by 256
Bone, H. G., Chapurlat, R., Brandi, M.-L., Brown, J. P., Czerwiński, E., Krieg, M.-A., Mellström, D., Radominski, S. C., Reginster, J.-Y., Resch, H., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1597 · Cited by 254
Otto, S., Schreyer, C., Hafner, S., Mast, G., Ehrenfeld, M., Stürzenbaum, S., & Pautke, C. (2012) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2011.05.003 · Cited by 252
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Meier, R. P. H., Perneger, T. V., Stern, R., Rizzoli, R., & Peter, R. E. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1796 · Cited by 239
Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
Cardwell, C. R., Abnet, C. C., Cantwell, M. M., & Murray, L. J. (2010) · JAMA · doi:10.1001/jama.2010.1098 · Cited by 224
Watts, N. B., Geusens, P., Barton, I. P., & Felsenberg, D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050814 · Cited by 164
Atypical Femoral Fractures and Bisphosphonate Use
Girgis, C. M., Sher, D., & Seibel, M. J. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910389 · Cited by 161
Abrahamsen, B., Eiken, P., & Eastell, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1571 · Cited by 160
Chen, P., Miller, P. D., Delmas, P. D., Misurski, D. A., & Krege, J. H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060802 · Cited by 158
Brown, J. P., Roux, C., Törring, O., Ho, P., Jensen, J. B., Gilchrist, N. L., Recknor, C. P., Austin, M., Wang, A., Grauer, A., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1808 · Cited by 153
Grbic, J. T., Landesberg, R., Lin, S., Mesenbrink, P. G., Reid, I. R., Leung, P., Casas, N., Recknor, C. P., Hua, Y., Delmas, P. D., et al. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0017 · Cited by 150
Wang, Z., & Bhattacharyya, T. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.233 · Cited by 148
Otto, S., Abu-Id, M. H., Fedele, S., Warnke, P. H., Becker, S. T., Kolk, A., Mücke, T., Mast, G., Köhnke, R. H., Volkmer, E., et al. (2010) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2010.05.009 · Cited by 147
Edwards, B. J.-A., Bunta, A. D., Lane, J. M., Odvina, C. V., Rao, D. S., Raisch, D. W., McKoy, J. M., Omar, I. M., Belknap, S. M., Garg, V., et al. (2013) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.k.01181 · Cited by 141
Freemantle, N., Cooper, C. C., Díez‐Pérez, A., Gitlin, M. D., Radcliffe, H.-S., Shepherd, S., & Roux, C. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2068-9 · Cited by 141
Vescovi, P., Campisi, G., Fusco, V., Mergoni, G., Manfredi, M., Merigo, E., Solazzo, L., Gabriele, M., Gaeta, G. M., Favia, G., et al. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2010.11.007 · Cited by 140
Schwartz, A. V., Schafer, A. L., Grey, A. B., Vittinghoff, E., Palermo, L., Lui, L., Wallace, R. B., Cummings, S. R., Black, D. M., Bauer, D. C., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1865 · Cited by 135
Sasaki, S., Miyakoshi, N., Hongo, M., Kasukawa, Y., & Shimada, Y. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0358-0 · Cited by 135
Chapurlat, R. D., Palermo, L., Ramsay, P., & Cummings, S. R. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1770-7 · Cited by 133
The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
Grbic, J. T., Black, D. M., Lyles, K. W., Reid, D. M., ORWOLL, E. S., McClung, M. R., Bucci-Rechtweg, C. M., & Su, G. (2010) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2010.0082 · Cited by 126
Clinical correlates of atypical femoral fracture
Lo, J. C.-M., Huang, S. Y., Lee, G. A., Khandewal, S., Provus, J., Ettinger, B. B., Gonzalez, J. R., Hui, R. L., & Grimsrud, C. D. (2012) · Bone · doi:10.1016/j.bone.2012.02.632 · Cited by 124
Bisphosphonates and Atrial Fibrillation
Loke, Y. K., Jeevanantham, V., & Singh, S. (2009) · Drug Safety · doi:10.2165/00002018-200932030-00004 · Cited by 119
Thompson, R. N., Phillips, J., McCauley, S. H., Elliott, J. R., & Moran, C. G. (2012) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.94b3.27999 · Cited by 114
Nationwide Survey for Bisphosphonate-Related Osteonecrosis of the Jaws in Japan
Urade, M., Tanaka, N., Furusawa, K., Shimada, J., Shibata, T., Kirita, T., Yamamoto, T., Ikebe, T., Kitagawa, Y., & Fukuta, J. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.03.051 · Cited by 113
Hopkins, R. B., Goeree, R. A., Pullenayegum, E., Adachi, J. D., Παπαϊωάννου, Α., Xie, F., & Thabane, L. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-209 · Cited by 103
Jansen, J. P., Bergman, G., Huels, J., & Olson, M. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.06.001 · Cited by 103
Kim, S. C., Schneeweiß, S., Katz, J. N., Levin, R., & Solomon, D. H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.288 · Cited by 97
Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture
Berry, S. D., Samelson, E. J., Pencina, M. J., McLean, R. R., Cupples, L. A., Broe, K. E., & Kiel, D. P. (2013) · JAMA · doi:10.1001/jama.2013.277817 · Cited by 88
Etminan, M., Forooghian, F., & Maberley, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111752 · Cited by 84
O’Ryan, F., & Lo, J. C.-M. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.08.033 · Cited by 84
The relation between bisphosphonate use and non-union of fractures of the humerus in older adults
Solomon, D. H., Hochberg, M. C., Mogun, H., & Schneeweiß, S. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0759-z · Cited by 83
Pazianas, M., Abrahamsen, B., Eiken, P., Eastell, R., & Russell, R. G. G. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1902-4 · Cited by 79
Tennis, P. S., Rothman, K. J., Bohn, R. L., Tan, H., Zavras, A. I., Laskarides, C., Calingaert, B., & Anthony, M. S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3292 · Cited by 77
Bisphosphonate adverse effects, lessons from large databases
Abrahamsen, B. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ad677 · Cited by 73
Solomon, D. H., Mercer, E., Woo, S. B., Avorn, J., Schneeweiß, S., & Treister, N. S. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2042-6 · Cited by 65
Exposure to oral bisphosphonates and risk of cancer
Cardwell, C. R., Abnet, C. C., Veal, P., Hughes, C. M., Cantwell, M. M., & Murray, L. (2011) · International Journal of Cancer · doi:10.1002/ijc.27389 · Cited by 65
Vinogradova, Y., Coupland, C. A. C., & Hippisley‐Cox, J. (2013) · BMJ · doi:10.1136/bmj.f114 · Cited by 63
Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab
Toulis, K. A., & Anastasilakis, A. D. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1145-1 · Cited by 63
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene
Vestergaard, P., Schwartz, F., Rejnmark, L., & Mosekilde, L. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1512-y · Cited by 62
For the MOVER Study Group, Nakamura, T., Nakano, T., Ito, M., Hagino, H., Hashimoto, J., Tobinai, M., & Mizunuma, H. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9734-6 · Cited by 59
Lee, Y., Ha, Y., Park, C., Yoo, J. J., Shin, C. S., & Koo, K. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2016-8 · Cited by 58
Freitas, M. D., López-Cedrún, J., Sanromán, J. F., García, A. G., Feijoo, J. F., & Dios, P. D. (2012) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.18041 · Cited by 58
Oral bisphosphonate use in the elderly is not associated with acute kidney injury
Shih, A. W. Y., Weir, M. A., Clemens, K. K., Yao, Z., Gomes, T., Mamdani, M., Juurlink, D. N., Hird, A. E., Hodsman, A. B., Parikh, C. R., et al. (2012) · Kidney International · doi:10.1038/ki.2012.227 · Cited by 55
Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates
Sharma, A., Chatterjee, S., Arbab‐Zadeh, A., Goyal, S., Lichstein, E., Ghosh, J., & Aikat, S. (2013) · CHEST Journal · doi:10.1378/chest.13-0675 · Cited by 54
Lee, S.-H., Chang, S.-S., Lee, M., Chan, R., & Lee, C. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2575-3 · Cited by 53
Barrett-Connor, E. L., Swern, A. S., Hustad, C. M., Bone, H., Liberman, U. A., Papapoulos, S. E., Wang, H., de Papp, A., & Santora, A. C. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1546-9 · Cited by 50
Hansen, P. J., Knitschke, M., Draenert, F. G., Irle, S., & Neff, A. (2012) · Clinical Oral Investigations · doi:10.1007/s00784-012-0873-3 · Cited by 49
Vieira, R. L. R., Rosenberg, Z. S., Allison, M. B., Im, S. A., Babb, J. S., & Peck, V. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7442 · Cited by 48
Tadrous, M., Wong, L., Mamdani, M., Juurlink, D. N., Krahn, M. D., Lévesque, L. E., & Cadarette, S. M. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2576-2 · Cited by 46
Nakamura, T., Shiraki, M., Fukunaga, M., Tomomitsu, T., Santora, A., Tsai, R., Fujimoto, G., Nakagomi, M., Tsubouchi, H., Rosenberg, E., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2398-2 · Cited by 45
Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis
Rhee, C. W., Lee, J.-S., Oh, S., Choi, N., & Park, B. J. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1608-z · Cited by 45
Hsiao, F., Huang, W.-F., Chen, Y., Wen, Y., Kao, Y.-H., Chen, L., & Tsai, Y. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.006 · Cited by 43
Pazianas, M., Clark, E., Eiken, P., Brixen, K., & Abrahamsen, B. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1783 · Cited by 43
Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)
Chapman, I., Greville, H. W., Ebeling, P. R., King, S., Kotsimbos, T. C., Nugent, P., Player, R., Topliss, D. J., Warner, J., & Wilson, J. W. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03434.x · Cited by 43
Hartle, J. E., Tang, X., Kirchner, H. L., Bucaloiu, I. D., Sartorius, J. A., Pogrebnaya, Z., Akers, G., Carnero, G. E., & Perkins, R. M. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.037 · Cited by 42
Burden of bisphosphonate‐associated femoral fractures
Shkolnikova, J., Flynn, J. A., & Choong, P. (2012) · ANZ Journal of Surgery · doi:10.1111/ans.12018 · Cited by 41
Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
Sun, K., Liu, J. M., Sun, H. X., Lu, N., & Ning, G. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2158-8 · Cited by 41
Vestergaard, P. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9539-4 · Cited by 41
Migliore, A., Broccoli, S., Massafra, U., Cassol, M., & Frediani, B. (2013) · PubMed · Cited by 41
Atypical Femur Fractures: 81 Individual Personal Histories
Schneider, J. P., Hinshaw, W. B., Su, C., & Solow, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2590 · Cited by 39
Chiang, C.-H., Huang, C., Chan, W., Huang, P., Chen, T., Chung, C., Lin, S., Chen, J., & Leu, H. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1645 · Cited by 39
A Prospective Study of Bisphosphonate Use and Risk of Colorectal Cancer
Khalili, H., Huang, E. S., Ogino, S., Fuchs, C. S., & Chan, A. T. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2670 · Cited by 38
Vinogradova, Y., Coupland, C. A. C., & Hippisley‐Cox, J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.383 · Cited by 38
Meta‐analysis: oral bisphosphonates and the risk of oesophageal cancer
Andrici, J., Tio, M., & Eslick, G. D. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12041 · Cited by 37
Bisphosphonates and risk of atrial fibrillation: a meta-analysis
Kim, S. C., Kim, M. J., Cadarette, S. M., & Solomon, D. H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2938 · Cited by 37
on behalf of the Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group, Lapi, F., Cipriani, F., Caputi, A. P., Corrao, G., Vaccheri, A., Sturkenboom, M., Bari, M. D., Gregori, D., Carle, F., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2013-y · Cited by 36
Femoral Stress Fractures Associated With Long-term Bisphosphonate Treatment
Ward, W. G., Carter, C. J., Wilson, S. C., & Emory, C. L. (2011) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-011-2194-2 · Cited by 35
Kang, J., Keller, J. J., & Lin, H. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1894-0 · Cited by 34
Kumagai, Y., Hasunuma, T., & Padhi, D. (2011) · Bone · doi:10.1016/j.bone.2011.08.007 · Cited by 34
Bocanegra-Perez, M., Barrero, M. V., Henríquez, M. S., Rodríguez‐Bocanegra, E., Limiñana-Cañal, J. M., Lopez-Marquez, A., Plasencia, D. P., & Macías, Á. R. (2012) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.17946 · Cited by 34
Dalal, S. R., Shekelle, P., Hempel, S., Newberry, S. J., Motala, A., & Shetty, K. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12457243 · Cited by 32
Self-citationRandomized controlled trial of zoledronic acid for treatment of osteoporosis in women
Bai, H., Jing, D., Guo, A., & Yin, S. (2013) · Journal of International Medical Research · doi:10.1177/0300060513480917 · Cited by 31
Fujita, T., Fukunaga, M., Itabashi, A., Tsutani, K., & Nakamura, T. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9777-8 · Cited by 30
Miller, P. D., Delmas, P. D., Huss, H., Patel, K., Schimmer, R. C., Adami, S., & Recker, R. R. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9403-y · Cited by 30
Zoledronic acid and atrial fibrillation in cancer patients
Arslan, Ç., Aksoy, S., Dızdar, Ö., Dede, D. Ş., Harputluoğlu, H., & Altundağ, K. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0868-z · Cited by 29
Nguyen, D., Schwartz, J. T., Richardson, P. A., & El‐Serag, H. B. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1198-1 · Cited by 29
Osteonecrosis of the Jaw in Older Osteoporosis Patients Treated with Intravenous Bisphosphonates
Baillargeon, J., Kuo, Y. F., Lin, Y., Wilkinson, G. S., & Goodwin, J. S. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q239 · Cited by 28
Pazianas, M., Abrahamsen, B., Wang, Y., & Russell, R. G. G. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1952-7 · Cited by 28
Lee, W.-Y., Sun, L.-M., Lin, M., Liang, J., Chang, S., Sung, F.-C., Muo, C., & Kao, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053032 · Cited by 27
Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases.
ALMĂŞAN, H. A., Băciuț, M. F., Rotaru, H., Bran, S., Almăşan, O. C., & Băciuț, G. (2011) · PubMed · Cited by 24
Heart failure in patients treated with bisphosphonates
Grove, E. L., Abrahamsen, B., & Vestergaard, P. F. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12087 · Cited by 23
Alendronate and Risk of Esophageal Cancer: A Nationwide Population‐Based Study in T aiwan
Chen, Y., Tsai, Y., Liu, C., Chen, Y.-T., Chang, L., Huang, W., Chen, D., Hsiao, F., & Chen, L. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03693.x · Cited by 22
Oral bisphosphonates and risk of ischemic stroke: a case–control study
Christensen, S., Mehnert, F., Chapurlat, R. D., Baron, J. A., & Sørensen, H. T. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1395-y · Cited by 20
Characteristics of Bisphosphonate-Related Osteonecrosis of the Jaw After Kidney Transplantation
Park, W., Lee, S.-H., Park, K.-R., Rho, S.-H., Chung, W., & Kim, H. J. (2012) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31825b33f6 · Cited by 18
Histological finding of atypical subtrochanteric fracture after long-term alendronate therapy
Kajino, Y., Kabata, T., Watanabe, K., & Tsuchiya, H. (2011) · Journal of Orthopaedic Science · doi:10.1007/s00776-011-0085-8 · Cited by 18
“Due” for a Scan: Examining the Utility of Monitoring Densitometry
Combs, B. P., Rappaport, M., Caverly, T. J., & Matlock, D. D. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.8998 · Cited by 17
Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis
Chao, M., Hua, Q., Yingfeng, Z., Guang, W., Shufeng, S., Dong, Y., Wang, W., & Haifeng, T. (2013) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.296.3677 · Cited by 17
Carmona, E. C., Flores, A. G., Loza, E., Olea, A. H., & Lozano, M. P. R. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2012.05.005 · Cited by 16
Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review
Warren, C., Gilchrist, N. L., Coates, M. H., Frampton, C. M., Helmore, J., McKie, J., & Hooper, G. J. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06199.x · Cited by 15
Simultaneous bilateral atypical femoral fractures after alendronate therapy.
Cp, Z., Stathopoulos, I. P., Kourkoumelis, G., Gkikas, E., & Lyritis, G. P. (2012) · PubMed · Cited by 14
Femoral shaft fractures in the elderly – Role of prior bisphosphonate therapy
Ng, Y. H., Gino, P. D., Lingaraj, K., & De, S. D. (2011) · Injury · doi:10.1016/j.injury.2010.12.019 · Cited by 13
Fitzpatrick, S. G., Stavropoulos, M. F., Bowers, L. M., Neuman, A. N., Hinkson, D. W., Green, J. G., Bhattacharyya, I., & Cohen, D. M. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.02.049 · Cited by 13
Adachi, J. D., Lyles, K. W., Boonen, S., Colon-Emeric, C. S., Hyldstrup, L., Nordsletten, L., Pieper, C. F., Recknor, C. P., Su, G., Bucci-Rechtweg, C. M., et al. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9543-8 · Cited by 12
Ghirardi, A., Scotti, L., Vedova, G. D., d’Oro, L. C., Lapi, F., Cipriani, F., Caputi, A. P., Vaccheri, A., Gregori, D., Gesuita, R., et al. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-5 · Cited by 10
Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
Villa, A., Castiglioni, S., Peretti, A., Omodei, M., Ferrieri, B. G., & Abati, S. (2011) · ISRN Rheumatology · doi:10.5402/2011/654027 · Cited by 9
Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem.
Murphy, C. G., O’Flanagan, S. J., Keogh, P., & Kenny, P. J. (2011) · PubMed · Cited by 9
Wright, E., Seed, P. T., Schofield, P., & Jones, R. H. (2010) · BMJ · doi:10.1136/bmj.c5315 · Cited by 4
Cited by
Black, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Qaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Metadata
- Authors
- Crandall, C. J., Newberry, S. J., Diamant, A., Lim, Y.-W., Gellad, W. F., Booth, M. J., Motala, A., & Shekelle, P. G.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2014-11-18
- Volume
- 161
- Issue
- 10
- Pages
- 711
- ISSN
- 0003-4819 (ISSN-L)
- OpenAlex
- W2002557904
- Cited by
- 254
- References
- 135
- FWCI
- 24.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.